Lv7
3280 积分 2024-06-01 加入
Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center
2天前
已完结
In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study
25天前
已完结
A phase 1 trial of prizloncabtagene autoleucel, a CD19/CD20 CAR T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma
1个月前
已完结
Cytokine storm
1个月前
已完结
Propensity Score-Matched analysis supports the survival benefits of combination chimeric antigen receptor T-cell therapy with autologous transplantation in relapsed or refractory diffuse large B-cell lymphoma: Insights from a real-world study in China
1个月前
已完结
Propensity Score-Matched Analysis Supports the Survival Benefits of Combination Chimeric Antigen Receptor T-Cell Therapy with Autologous Transplantation in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Insights from a Real-World Study in China
3个月前
已完结
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
4个月前
已完结
Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
4个月前
已完结
Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis
5个月前
已完结
皖公网安备34019202002308
